Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: A promising low-toxic regimen

Anticancer Research

Volumn 21, Issue 6 A, 2001, Pages 4135-4139

  Orlando, L ^a   Colleoni, M ^a   Curigliano, G ^a   Nole F ^a   Ferretti, G ^a   Masci, G ^a   Peruzzotti, G ^a   Minchella, I ^a   Intra, M ^a   Veronesi, P ^a   Viale, G ^a   Goldhirsch, A ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

5 fluorouracil; Breast cancer; Chemotherapy; Cisplatin; Vinorelbine

Indexed keywords

CISPLATIN; FLUOROURACIL; NAVELBINE;

ACUTE TOXICITY; ADULT; AGED; ALOPECIA; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG INFUSION; DRUG RESPONSE; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HUMAN; METASTASIS; MUCOSA INFLAMMATION; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; NEOPLASM STAGING; VINBLASTINE;

EID: 0035570353     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Locally advanced breast cancer. A review including the MD. Anderson
2. Natural history and survival of inoperable breast cancer treated with radiotherapy and followed by radical mastectomy
3. Inflammatory breast cancer: Determination of prognostic factors by univariate and multivariate analysis
4. Management of stage III primary breast cancer with primary chemotherapy, surgery and radiation therapy
5. Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer
6. Multimodal treatment of locoregionally advanced breast cancer
7. Multimodal treatment for locally advanced breast cancer
8. Neoadjuvant chemotherapy in the combined modality approach of locally advanced non metastatic breast cancer
9. Six-year results of a multimodality treatmenl strategy for locally advanced breast cancer
10. A mathematic model for relating the drug sensitivity of tumors to spontaneous mutation rate
11. High complete remision rates with primary neoadjuvant infusional chemotherapy for large early breast cancer
12. Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: An active new regimen
13. Neoadjuvant chemotherapy (CT) with FNC (fluorouracil, mitoxantrone, cyclophosphamide) in operable locally advanced breast cancer (LABC) allows breast conservation
14. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm: Results of a randomized trial in a single center
15. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer
16. Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumors considered too large for breast conserving surgery: Preliminary results of a randomized trial
17. Effect of preoperative therapy in local-regional disease in women with operable breast cancer: Findings from the National Surgical Adjuvant Breast and Bowel Project B-18
18. Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation in 98 patients with locally advanced beast cancer (IIIA-IIIB)
19. Pathological assessment of response to induction chemotherapy in breast cancer
20. Preoperative chemotherapy operable breast cancer
21. 5-Fluorouracil: A reappraisal of optimal delivery in advanced beast cancer
22. Biochemical basis for cisplatinum and 5-fluoruracil synergism in human tumors
23. A new class of antitumor compounds: 5'-nor and 5',6'-seco derivatives of vinblastine-type alkaloids
24. Phase II study of Navelbine in advanced breast cancer
25. Delozier T et al. Phase II trial of weekly intravenous vinorelbine in first line advanced breast cancer chemotherapy
26. Primary chemotherapy in operable or locally advanced breast cancer (OLABC) using a regimen containing vinorelbine (V), cisplatin (P), and continuous infusion of fluorouracil (Fu i.c.)
27. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma
28. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer
29. Combined chemotherapy and radiotherapy for locally advanced breast cancer
30. Inflammatory breast cancer: A review
31. Primary chemotherapy in the treatment of inflammatory breast carcinoma: A study of 230 cases from Institute Gustave-Roussy
32. Final results of a Phase II randomized, parallel study of Doxorubicin/Cyclophosphamide (AC) and Doxorubicin/Taxol (paclitaxel) (AT) as neoadjuvant treatment of local-regional breast cancer
33. Prolonged neoadjuvant treatment in locally advanced tumours: A novel concept based on biological considerations
34. Prediction of response to primary chemotherapy for operable breast cancer